Altering biologic regimens may be required in those who develop skin cancer
from Dermatology Times via Modern Medicine
With conflicting evidence regarding the true risk of nonmelanoma skin cancers in patients taking biologic drugs for psoriasis, Dr. Oscar Colegio says physicians should consider treatment options for patients in this category on a case-by-case basis. Among the many patients a dermatologist will see, "It is virtually inevitable that a patient with either a personal history of NMSC or at high risk for developing NMSC will present to your office with severe psoriasis, in need of systemic therapy," Colegio says.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063